We are monitoring the impact of COVID-19 on North America Antiviral Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1509
Share on
Share on

North America Antiviral Drugs Market Research Report - Segmented By Application , By Target, End Users & Country (U.S, Canada & Rest of North America)- Industry Analysis, Size, Share, Growth, Trends, & Forecasts | 2021 to 2026

Pulished: April, 2021
ID: 1509
Pages: 135

North America Antiviral Drugs Market Size & Growth (2021 to 2026):

As per the research report, the size of the North America Antiviral Drugs Market is valued at USD 14.23 billion in 2021 and is expected to reach USD 17.71 billion by 2026, growing at a CAGR of 4.47% during the forecast period 2021 to 2026.

DRIVERS

The increasing prevalence of viral infections such as HIV and influenza along with increasing R&D activities and development of newer and advanced formulations are the few factors responsible for the high growth rate of the market during the forecast period. According to the CDC, the prevalence of oral herpes (HSV-1) and genital herpes (HSV-2) was 48% and 12%, respectively, from 2018 to 2019. The Herpes Resource Center (HRC) Raises Public Awareness, Educates and Support. In addition, the Hepatitis B Foundation gives information on the diagnosis, preventive measures and treatment modalities. The increase in preventative measures with the availability of various vaccines is expected to hamper the growth of the North America antiviral drugs market during the forecast period.

According to the Joint United Nations Program on HIV / AIDS (UNAIDS), approximately 38.9 million people worldwide were infected with HIV in 2019. Of these, approximately 1.84 million people contracted HIV in 2019 On top of that, over 690,500 people have died of AIDS. These numbers suggest that access to therapeutic antiviral drugs continues to increase, which is the main driver of market growth. Moreover, the strong R&D development by major bio-pharmaceutical companies, along with the increase in product launches, are the main drivers for the growth of the North America antiviral drugs market.

RESTRAINTS

However, the high cost of antiviral drug therapy may hamper the market growth in developing regions.

OPPORTUNITIES

There is an increasing development in molecular biology which is promoting drug development and the increasing adoption of nucleosides and nucleotide analogs as first-line antiviral treatment regimens. Based on the current development line in the market, it is expected that many small molecule antiviral drugs will receive product approvals in the future, which will take the market growth to huge heights.

CHALLENGES

Strong competition among various products and bringing antiviral drugs to market in underdeveloped areas is difficult and time consuming, so they can jeopardize the growth rate of the market.

This research report on the North America Antiviral Drugs Market has been segmented and sub-segmented into the following categories:

By Application:

  • HIV/AIDS
  • Hepatitis
  • Herpes
  • Influenza
  • Others

By Target:

  • DNA Polymerase
  • NS3 Protease
  • Reverse Transcriptase
  • Others

By End Users:

  • Hospitals
  • Research Institutes
  • Laboratory Centers

By Country:

  • U.S
  • Canada
  • Rest of North America

REGIONAL ANALYSIS

North America is expected to dominate the antiviral therapy market, owing to the presence of established players in the market and the increasing prevalence of HIV and other viral infections.

The U.S Antiviral Drugs Market will hold large share in the North America region. The market growth in the U.S region is attributed to the increased investment in research and development by major companies and the strong drug approval by the Food and Drug Administration (FDA) from the United States in recent years. Additionally, to stimulate market growth in the current covid -19 pandemic situation, the federal government is providing support funds to pharmaceutical companies to help them strengthen their clinical development lines. For example, in 2020, the United States federal government to manufactured COVID-19 drugs and vaccines with public funds. Hence, owing to the above mentioned factors, it is expected to drive the market growth in North America region during the forecast period. Canada Antiviral Drugs Market will also have a healthy steady growth rate in the upcoming years owing to improving healthcare infrastructure in the region.

Companies playing a dominant role in the North America Antiviral Drugs Market profiled in this report are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 HIV/AIDS

                                5.1.3 Hepatitis  

                                5.1.4 Herpes     

                                5.1.5 Influenza 

                                5.1.6 Others      

                                5.1.7 Y-o-Y Growth Analysis, By Application         

                                5.1.8 Market Attractiveness Analysis, By Application        

                                5.1.9 Market Share Analysis, By Application         

                5.2 Target                           

                                5.2.1 Introduction           

                                5.2.2 DNA polymerase  

                                5.2.3 NS3 Protease         

                                5.2.4 Reverse transcriptase        

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Target   

                                5.2.7 Market Attractiveness Analysis, By Target

                                5.2.8 Market Share Analysis, By Target   

                5.3 End Users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals/Clinics   

                                5.3.3 Research Institutes             

                                5.3.4 Laboratory Centers             

                                5.3.5 Y-o-Y Growth Analysis, By End Users            

                                5.3.6 Market Attractiveness Analysis, By End Users          

                                5.3.7 Market Share Analysis, By End Users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Target

                                                6.1.3.4 By End-Users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Target

                                                6.1.4.4 By End-Users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Target

                                                6.1.5.4 By End-Users

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Johnson & Johnson                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis International AG                     

                8.3 Roche Holding AG                   

                8.4 Pfizer                            

                8.5 Merck and Co. Inc                    

                8.6 GlaxoSmithKline plc                

                8.7 AstraZeneca AB                        

                8.8 Gilead Sciences                         

                8.9 Abbott Laboratories               

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  2. North America HIV/AIDS  Market By Region, From 2021 to 2026 ( USD Billion )
  3. North America Hepatitis Market By Region, From 2021 to 2026 ( USD Billion )
  4. North America Herpes Market By Region, From 2021 to 2026 ( USD Billion )
  5. North America Influenza Market By Region, From 2021 to 2026 ( USD Billion )
  6. North America Others Market By Region, From 2021 to 2026 ( USD Billion )
  7. North America Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  8. North America DNA polymerase Market By Region, From 2021 to 2026 ( USD Billion )
  9. North America NS3 Protease Market By Region, From 2021 to 2026 ( USD Billion )
  10. North America Reverse transcriptase Market By Region, From 2021 to 2026 ( USD Billion )
  11. North America Others Market By Region, From 2021 to 2026 ( USD Billion )
  12. North America Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )
  13. North America Hospitals/Clinics Market By Region, From 2021 to 2026 ( USD Billion )
  14. North America Research Institutes Market By Region, From 2021 to 2026 ( USD Billion )
  15. North America Laboratory Centers Market By Region, From 2021 to 2026 ( USD Billion )
  16. United States Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  17. United States Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  18. United States Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )
  19. Canada Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  20. Canada Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  21. Canada Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample